CS logo
small CS logo
Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii

Gdynia, Poland
Hospital department in Gdynia
Powstania Styczniowego 1, 81-519 Gdynia

About Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


During the past decade, Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


According to Clinical.Site data, the most researched conditions in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" are "Early Breast Cancer" (2 trials), "MELANOMA" (1 trials), "Metastatic Breast Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" in a lesser frequency.

Clinical Trials Intervention Types at Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


Most popular intervention types in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" are "Drug" (8 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Giredestrant" (2 trials), "Anastrozole" (1 trials), "Atezolizumab" (1 trials), "Avelumab" (1 trials) and "Capecitabine + bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


The vast majority of trials in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii" are 4 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii


Currently, there are NaN active trials in "Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Szpitale Pomorskie Sp. z o.o. Oddzial Onkologii i Radioterapii, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".